InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,691.60
(
0.29%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
83.88
(
-0.09%
)
Bitcoin
62,920.28
(
-0.20%
)
Post# of 20496
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dDT

Send PM Follow Ignore
Followers 470
Posts 76416
Boards Moderated 3
Alias Born 03/31/2008

dDT

Re: None

Thursday, 09/20/2012 4:32:09 PM

Thursday, September 20, 2012 4:32:09 PM

Post# of 20496
Progenics Pharmaceuticals (PGNX) announces a company-wide restructuring , including a reduction of its workforce by 26%, to 77 employees, and the termination of several early stage research projects. The company will continue to focus on its oncology programs, adding that clinical development and manufacturing capabilities will also be unaffected. In additon, CFO Robert McKinney and SVP of Quality Benedict Osorio will be stepping down, effective September 30. Shares -1.1% AH.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up